Sympti
PrivateLast Round
Accelerator
Dec 17, 2020
Total Funding Raised
$150,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Sympti is a healthtech company that provides an artificial intelligence-driven medical service platform for patients to find and book urgent care, emergency rooms, and telehealth visits.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Healthcare Analytics, Medical AI, Vertical SaaS, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sympti Comparables
Compare Sympti with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clearstep | 86% | |
| DexCare | 78% | |
| Infermedica | 78% | |
Sympti Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Dec 17, 2020 | ||||
| Accelerator | Jun 5, 2018 |
Sympti Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Quake Capital | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors grew 73% MoM.
- Dec 17, 2020
Completed an Accelerator round of funding.
Sympti Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sympti's valuation, stock price, and market status.